Abstract:Theranostic nanoplatforms for combination tumor therapy have gained lots of attention recently due to the optimized therapeutic efficiency and simultaneous diagnosis performance. Herein, a novel tumor microenvironment (TME)-responsive core-shell tecto dendrimer (CSTD) was assembled by phenylboronic acid- and mannose-modified poly(amidoamine) dendrimers via the phenylboronic ester bonds that are responsive to low pH and reactive oxygen species (ROS), and efficiently loaded with copper ions and chemotherapeutic drug disulfiram (DSF) for tumor-targeted magnetic resonance (MR) imaging and cuproptosis-promoted chemo-chemodynamic therapy. The formed CSTD-Cu(II)@DSF could be specifically taken up by MCF-7 breast cancer cells, accumulated to the tumor model after circulation, and released drugs in response to the weakly acidic TME with overexpressed ROS. The enriched intracellular Cu(II) ions could induce the oligomerization of lipoylated proteins and proteotoxic stress for cuproptosis, and lipid peroxidation for chemodynamic therapy as well. Moreover, the CSTD-Cu(II)@DSF could cause the dysfunction of mitochondria and arrest the cell cycle at the G2/M phase, leading to enhanced DSF-mediated cell apoptosis. As a result, CSTD-Cu(II)@DSF could effectively inhibit the growth of MCF-7 tumors by a combination therapy strategy integrating chemotherapy with cuproptosis and chemodynamic therapy. Lastly, the CSTD-Cu(II)@DSF also displays Cu(II)-associated r1 relaxivity, allowing for T1-weighted real-time MR imaging of tumors in vivo. The developed tumor-targeted and TME-responsive CSTD-based nanomedicine formulation may be developed for accurate diagnosis and synergistic treatment of other cancer types. STATEMENT OF SIGNIFICANCE: Constructing an effective nanoplatform for the combination of therapeutic effects and real-time tumor imaging remains a challenge. In this study, we reported for the first time an all-in-one tumor-targeted and tumor microenvironment (TME) responsive nanoplatform based on core-shell tecto dendrimer (CSTD) for the cuproptosis-promoted chemo-chemodynamic therapy and enhanced MR imaging. The efficient loading, selective tumor-targeting, and TME-responsive release of Cu(II) and disulfiram could enhance the intracellular accumulation of drugs, induce cuproptosis of cancer cells, and amplify the synergistic chemo-chemodynamic therapeutic effect, resulting in enhanced MR imaging and accelerated tumor eradication. This study sheds new light on the development of theranostic nanoplatforms for early accurate diagnosis and effective treatment of cancers.

A Ph-Responsive Platform Combining Chemodynamic Therapy with Limotherapy for Simultaneous Bioimaging and Synergistic Cancer Therapy.

Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment

Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy

Theranostic Nanoplatform Based on Polydopamine-Coated Magnetic Mesoporous Silicon for Precise Cancer Triplex Nanotherapy and Multimodal Imaging

A Biodegradable MnSiO3@Fe3O4 Nanoplatform for Dual-Mode Magnetic Resonance Imaging Guided Combinatorial Cancer Therapy.

A Tumor Microenvironment-Responsive Core-Shell Tecto Dendrimer Nanoplatform for Magnetic Resonance Imaging-Guided and Cuproptosis-Promoted Chemo-Chemodynamic Therapy.

Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief.

Tumor Microenvironment-Adaptive Nanoplatform Synergistically Enhances Cascaded Chemodynamic Therapy

Tumor Microenvironment-Responsive MnSiO3-Pt@BSA-Ce6 Nanoplatform for Synergistic Catalysis-Enhanced Sonodynamic and Chemodynamic Cancer Therapy

An Efficient Tumor-Inducible Nanotheranostics for Magnetic Resonance Imaging and Enhanced Photodynamic Therapy

A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging

Multifunctional Ce6-loaded MnO 2 as an Oxygen-Elevated Nanoplatform for Synergistic Photodynamic/Photothermal therapy

Nanoplatforms with synergistic redox cycles and rich defects for activatable image-guided tumor-specific therapy

A novel intratumoral pH/redox-dual-responsive nanoplatform for cancer MR imaging and therapy

Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy

Dual-targeting nanotheranostics for MRI-guided enhanced chemodynamic therapy of hepatoma via regulating the tumor microenvironment

Intelligent MoS2-CuO Heterostructures with Multiplexed Imaging and Remarkably Enhanced Antitumor Efficacy Via Synergetic Photothermal Therapy/ Chemodynamic Therapy/ Immunotherapy.

Sequential Catalytic, Magnetic Targeting Nanoplatform for Synergistic Photothermal and NIR-Enhanced Chemodynamic Therapy

A Tumor-Microenvironment Fully Responsive Nano-Platform for MRI-guided Photodynamic and Photothermal Synergistic Therapy

A HMCuS@MnO2 nanocomplex responsive to multiple tumor environmental clues for photoacoustic/fluorescence/magnetic resonance trimodal imaging-guided and enhanced photothermal/photodynamic therapy

Tumor-Microenvironment-Induced All-in-One Nanoplatform for Multimodal Imaging-Guided Chemical and Photothermal Therapy of Cancer